These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31900031)

  • 1. A regulatory role for CHD2 in myelopoiesis.
    Shahin Varnoosfaderani F; Palau A; Dong W; Persson J; Durand-Dubief M; Svensson JP; Lennartsson A
    Epigenetics; 2020; 15(6-7):702-714. PubMed ID: 31900031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C; Petruzzelli L; Herrera R
    Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells.
    Peng H; Du ZW; Zhang JW
    Leukemia; 2006 Jun; 20(6):1109-16. PubMed ID: 16628192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF300 knockdown inhibits forced megakaryocytic differentiation by phorbol and erythrocytic differentiation by arabinofuranosyl cytidine in K562 cells.
    Cai J; Gong R; Yan F; Yu C; Liu L; Wang W; Lin Y; Guo M; Li W; Huang Z
    PLoS One; 2014; 9(12):e114768. PubMed ID: 25485965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
    J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation.
    Huo XF; Yu J; Peng H; Du ZW; Liu XL; Ma YN; Zhang X; Zhang Y; Zhao HL; Zhang JW
    Mol Cell Biochem; 2006 Nov; 292(1-2):155-67. PubMed ID: 16786195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
    Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor egr-1 is involved in phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Cheng T; Wang Y; Dai W
    J Biol Chem; 1994 Dec; 269(49):30848-53. PubMed ID: 7983016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor potentiated the sodium butyrate- and PMA-induced megakaryocytic differentiation of K562 leukemia cells.
    Xie P; Chan FS; Ip NY; Leung M
    Leuk Res; 2000 Sep; 24(9):751-9. PubMed ID: 10978779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 Tat protein enhances megakaryocytic commitment of K562 cells by facilitating CREB transcription factor coactivation by CBP.
    Williams CA; Mondal D; Agrawal KC
    Exp Biol Med (Maywood); 2005 Dec; 230(11):872-84. PubMed ID: 16339753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
    Lee CH; Yun HJ; Kang HS; Kim HD
    IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
    Dai W; Murphy MJ
    Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput transcription profiling identifies putative epigenetic regulators of hematopoiesis.
    Prasad P; Rönnerblad M; Arner E; Itoh M; Kawaji H; Lassmann T; Daub CO; Forrest AR; Lennartsson A; Ekwall K;
    Blood; 2014 Apr; 123(17):e46-57. PubMed ID: 24671951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
    Chou CC; Yung BY; Hsu CY
    Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells.
    Chaman N; Iqbal MA; Siddiqui FA; Gopinath P; Bamezai RN
    J Biol Chem; 2015 Sep; 290(39):23803-15. PubMed ID: 26269597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1.
    Ishiko E; Matsumura I; Ezoe S; Gale K; Ishiko J; Satoh Y; Tanaka H; Shibayama H; Mizuki M; Era T; Enver T; Kanakura Y
    J Biol Chem; 2005 Feb; 280(6):4929-39. PubMed ID: 15563463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
    Pettiford SM; Herbst R
    Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.
    Murray NR; Baumgardner GP; Burns DJ; Fields AP
    J Biol Chem; 1993 Jul; 268(21):15847-53. PubMed ID: 8340409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
    Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
    Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation.
    Cheng T; Erickson-Miller CL; Li C; Cardier J; Wang Y; Dempsey J; Mogle M; Barbera E; Murphy MJ; Dai W
    Leukemia; 1995 Jul; 9(7):1257-63. PubMed ID: 7543177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.